GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » 3-Year Dividend Growth Rate

Evolva Holding (XSWX:EVE) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Evolva Holding 3-Year Dividend Growth Rate?

Evolva Holding's Dividends per Share for the six months ended in Jun. 2023 was CHF0.00.

The historical rank and industry rank for Evolva Holding's 3-Year Dividend Growth Rate or its related term are showing as below:

XSWX:EVE's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 13.55
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Evolva Holding's Dividend Payout Ratio for the six months ended in Jun. 2023 was 0.00. As of today, Evolva Holding's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Evolva Holding's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Evolva Holding's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolva Holding's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Evolva Holding's 3-Year Dividend Growth Rate falls into.


Evolva Holding 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Evolva Holding  (XSWX:EVE) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Evolva Holding's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2023 )/ EPS without NRI (Q: Jun. 2023 )
=0/ -8.45
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolva Holding 3-Year Dividend Growth Rate Related Terms>

Evolva Holding (XSWX:EVE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » 3-Year Dividend Growth Rate
Comparable Companies
XSWX:KNRS XSWX:SPEX XSWX:ADXN XSWX:RLF OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
ELVAF:USA EVEz:UK
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Website
https://www.evolva.com
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.